000048428 000__ 01439cam\a22003855i\4500
000048428 001__ 48428
000048428 003__ SzGeWIPO
000048428 005__ 20240708150405.0
000048428 006__ m\\\\eo\\d\\\\\\\\
000048428 007__ cr bn |||m|||a
000048428 008__ 230714s2023    nyu|||||o|||||000|0 eng|d
000048428 035__ $$a(OCoLC)1393693945
000048428 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000048428 041__ $$aeng
000048428 24500 $$aEuropean Union: Novartis Pharma.
000048428 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2023
000048428 300__ $$a1 online resource
000048428 336__ $$atext$$2rdacontent
000048428 337__ $$acomputer$$2rdamedia
000048428 338__ $$aonline resource$$bcr$$2rdacarrier
000048428 4901_ $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 3
000048428 542__ $$fhttps://1.next.westlaw.com/Copyright
000048428 588__ $$aCrossref
000048428 590__ $$aPublished online: 2023
000048428 650_0 $$aIntellectual property.$$zEuropean Union.
000048428 650_0 $$aTrademarks$$zEuropean Union.
000048428 650_0 $$aPharmaceuticals.
000048428 650_0 $$aIntellectual property.
000048428 650_0 $$aTrademarks.
000048428 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000048428 7731_ $$wIIC
000048428 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 3.
000048428 85641 $$uhttps://www.westlaw.com/Document/I862D4E40DD7D11ED999BD7C0C2185523/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000048428 904__ $$aJournal article
000048428 980__ $$aIIC